The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection

References

Page 1

	Year	Citations
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method Kenneth J. Livak, Thomas D. Schmittgen Methods Functional GenomicsEngineeringMedicineGeneticsGene Recognition	2001	176.9K
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection Journal of Hepatology	2012	2.9K
CXCR3 in T cell function Joanna R. Groom, Andrew D. Luster Experimental Cell Research Signal TransductionT Cell FunctionAdaptive Immune SystemT-regulatory CellImmunology	2011	976
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome Laura Belloni, Lena Allweiss, Francesca Guerrieri, Journal of Clinical Investigation Viral ReplicationActive CccdnaImmunologyMolecular BiologyCell Culture	2012	563
GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees Robert E. Lanford, Bernadette Guerra, Deborah Chavez, Gastroenterology Host ResponseViral HepatitisOral AgonistImmunologyHumoral Response	2013	367
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues Carolina Boni, Diletta Laccabue, Pietro Lampertico, Gastroenterology Ide AnaloguesMedicineT-regulatory CellLong-term Effective TherapyImmunology	2012	358
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN Isabelle Bekeredjian‐Ding, Moritz Wagner, Veit Hornung, The Journal of Immunology	2005	347
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus Nan Shen, Qiong Fu, Yun Deng, Proceedings of the National Academy of Sciences	2010	338
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B L. Micco, Dimitra Peppa, Elisabetta Loggi, Journal of Hepatology Viral HepatitisMedicineImmunologyHepatitis BHepatitis	2012	243
Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity Haifeng C. Xu, Melanie Grusdat, Aleksandra A. Pandyra, Immunity Autoimmune DiseaseImmunologyAntiviral ResponseImmunologic MechanismAutoimmunity	2014	224

Page 1